Combination therapy using Cel-CSO/Taxol NPs for reversing drug resistance in breast cancer through inhibiting PI3K/AKT/NF-κB/HIF-1α pathway
Article in Drug Delivery and Translational Research (June 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Drug Delivery and Translational Research (June 2024)
Article in Journal of Nanobiotechnology (December 2023)
Article in European Journal of Medicinal Chemistry (July 2023)